HEADER TOXIN 29-JUL-05 2AIB TITLE BETA-CINNAMOMIN IN COMPLEX WITH ERGOSTEROL COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-ELICITIN CINNAMOMIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PHYTOPHTHORA CINNAMOMI; SOURCE 3 ORGANISM_TAXID: 4785; SOURCE 4 GENE: CIN1B; SOURCE 5 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: SMD1168; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PIC9K KEYWDS ELICITIN, STEROL CARRIER PROTEIN, PHYTOPHTHORA, PHYTOPATHOGEN, TOXIN EXPDTA X-RAY DIFFRACTION AUTHOR M.L.RODRIGUES,M.ARCHER,P.MARTEL,S.MIRANDA,M.THOMAZ,F.J.ENGUITA, AUTHOR 2 R.P.BAPTISTA,E.P.MELO,N.SOUSA,A.CRAVADOR,M.A.CARRONDO REVDAT 6 30-OCT-24 2AIB 1 REMARK REVDAT 5 23-AUG-23 2AIB 1 REMARK REVDAT 4 13-JUL-11 2AIB 1 VERSN REVDAT 3 24-FEB-09 2AIB 1 VERSN REVDAT 2 14-FEB-06 2AIB 1 JRNL REVDAT 1 17-JAN-06 2AIB 0 JRNL AUTH M.L.RODRIGUES,M.ARCHER,P.MARTEL,S.MIRANDA,M.THOMAZ, JRNL AUTH 2 F.J.ENGUITA,R.P.BAPTISTA,E.P.MELO,N.SOUSA,A.CRAVADOR, JRNL AUTH 3 M.A.CARRONDO JRNL TITL CRYSTAL STRUCTURES OF THE FREE AND STEROL-BOUND FORMS OF JRNL TITL 2 BETA-CINNAMOMIN JRNL REF BIOCHIM.BIOPHYS.ACTA V.1764 110 2006 JRNL REFN ISSN 0006-3002 JRNL PMID 16249127 JRNL DOI 10.1016/J.BBAPAP.2005.09.008 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.L.RODRIGUES,M.ARCHER,P.MARTEL,A.JACQUET,A.CRAVADOR, REMARK 1 AUTH 2 M.A.CARRONDO REMARK 1 TITL STRUCTURE OF BETA-CINNAMOMIN, A PROTEIN TOXIC TO SOME PLANT REMARK 1 TITL 2 SPECIES. REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 58 1314 2002 REMARK 1 REFN ISSN 0907-4449 REMARK 1 PMID 12136143 REMARK 1 DOI 10.1107/S0907444902010107 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.DUCLOS,A.FAUCONNIER,A.C.COELHO,A.BOLLEN,A.CRAVADOR, REMARK 1 AUTH 2 E.GODFROID REMARK 1 TITL IDENTIFICATION OF AN ELICITIN GENE CLUSTER IN PHYTOPHTHORA REMARK 1 TITL 2 CINNAMOMI. REMARK 1 REF DNA SEQ. V. 9 231 1998 REMARK 1 REFN ISSN 1042-5179 REMARK 1 PMID 10520754 REMARK 2 REMARK 2 RESOLUTION. 1.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.119 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.119 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.150 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 3872 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 76981 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1428 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 82 REMARK 3 SOLVENT ATOMS : 454 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.015 REMARK 3 ANGLE DISTANCES (A) : 0.031 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.305 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : NULL REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : NULL REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2AIB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-AUG-05. REMARK 100 THE DEPOSITION ID IS D_1000033929. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUN-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 76981 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.100 REMARK 200 RESOLUTION RANGE LOW (A) : 49.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.03400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 24.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.13 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.37500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1BXM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, MES BUFFER, AMMONIUM REMARK 280 SULFATE, PH 6.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 31.38950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 LEU B 98 C LEU B 98 OXT 0.184 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 70 CB - CG - OD2 ANGL. DEV. = -5.8 DEGREES REMARK 500 TYR B 12 CB - CG - CD2 ANGL. DEV. = -3.7 DEGREES REMARK 500 TYR B 12 CB - CG - CD1 ANGL. DEV. = 3.6 DEGREES REMARK 500 MET B 35 CA - CB - CG ANGL. DEV. = 12.2 DEGREES REMARK 500 LYS B 61 CD - CE - NZ ANGL. DEV. = 31.6 DEGREES REMARK 500 TYR B 85 CB - CG - CD2 ANGL. DEV. = -3.9 DEGREES REMARK 500 TYR B 85 CD1 - CG - CD2 ANGL. DEV. = 7.7 DEGREES REMARK 500 TYR B 85 CB - CG - CD1 ANGL. DEV. = -3.7 DEGREES REMARK 500 TYR B 85 CG - CD1 - CE1 ANGL. DEV. = -5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ERG A 475 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ERG B 476 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES A 477 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 478 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 479 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2A8F RELATED DB: PDB REMARK 900 THE STRUCTURE WHICH IS BEING DEPOSITED AND THE STRUCTURE WITH THE REMARK 900 PDB CODE 2A8F WERE OBTAINED USING THE SAME RECOMBINANT PROTEIN REMARK 900 (BETA-CINNAMOMIN WITH AN ERGOSTEROL MOLECULE BOUND TO THE LIGAND REMARK 900 CAVITY), BUT THE 2A8F WAS OBTAINED AFTER LIGAND REMOVAL. THEREFORE, REMARK 900 THE TWO STRUCTURES CORRESPOND TO BOUND AND FREE FORMS OF BETA- REMARK 900 CINNAMOMIN, RESPECTIVELY. DBREF 2AIB A 1 98 UNP P15569 ELIB_PHYCI 1 98 DBREF 2AIB B 1 98 UNP P15569 ELIB_PHYCI 1 98 SEQRES 1 A 98 THR ALA CYS THR ALA THR GLN GLN THR ALA ALA TYR LYS SEQRES 2 A 98 THR LEU VAL SER ILE LEU SER GLU SER SER PHE SER GLN SEQRES 3 A 98 CYS SER LYS ASP SER GLY TYR SER MET LEU THR ALA THR SEQRES 4 A 98 ALA LEU PRO THR ASN ALA GLN TYR LYS LEU MET CYS ALA SEQRES 5 A 98 SER THR ALA CYS ASN THR MET ILE LYS LYS ILE VAL ALA SEQRES 6 A 98 LEU ASN PRO PRO ASP CYS ASP LEU THR VAL PRO THR SER SEQRES 7 A 98 GLY LEU VAL LEU ASP VAL TYR THR TYR ALA ASN GLY PHE SEQRES 8 A 98 SER SER LYS CYS ALA SER LEU SEQRES 1 B 98 THR ALA CYS THR ALA THR GLN GLN THR ALA ALA TYR LYS SEQRES 2 B 98 THR LEU VAL SER ILE LEU SER GLU SER SER PHE SER GLN SEQRES 3 B 98 CYS SER LYS ASP SER GLY TYR SER MET LEU THR ALA THR SEQRES 4 B 98 ALA LEU PRO THR ASN ALA GLN TYR LYS LEU MET CYS ALA SEQRES 5 B 98 SER THR ALA CYS ASN THR MET ILE LYS LYS ILE VAL ALA SEQRES 6 B 98 LEU ASN PRO PRO ASP CYS ASP LEU THR VAL PRO THR SER SEQRES 7 B 98 GLY LEU VAL LEU ASP VAL TYR THR TYR ALA ASN GLY PHE SEQRES 8 B 98 SER SER LYS CYS ALA SER LEU HET ERG A 475 29 HET MES A 477 12 HET ERG B 476 29 HET GOL B 478 6 HET GOL B 479 6 HETNAM ERG ERGOSTEROL HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 ERG 2(C28 H44 O) FORMUL 4 MES C6 H13 N O4 S FORMUL 6 GOL 2(C3 H8 O3) FORMUL 8 HOH *454(H2 O) HELIX 1 1 THR A 4 VAL A 16 1 13 HELIX 2 2 SER A 17 SER A 20 5 4 HELIX 3 3 GLU A 21 GLY A 32 1 12 HELIX 4 4 THR A 43 SER A 53 1 11 HELIX 5 5 SER A 53 LEU A 66 1 14 HELIX 6 6 VAL A 84 SER A 97 1 14 HELIX 7 7 THR B 4 VAL B 16 1 13 HELIX 8 8 SER B 17 SER B 20 5 4 HELIX 9 9 GLU B 21 GLY B 32 1 12 HELIX 10 10 THR B 43 ALA B 52 1 10 HELIX 11 11 SER B 53 LEU B 66 1 14 HELIX 12 12 VAL B 84 GLY B 90 1 7 HELIX 13 13 GLY B 90 SER B 97 1 8 SHEET 1 A 2 ASP A 72 THR A 74 0 SHEET 2 A 2 VAL A 81 ASP A 83 -1 O LEU A 82 N LEU A 73 SHEET 1 B 2 ASP B 72 THR B 74 0 SHEET 2 B 2 VAL B 81 ASP B 83 -1 O LEU B 82 N LEU B 73 SSBOND 1 CYS A 3 CYS A 71 1555 1555 2.01 SSBOND 2 CYS A 27 CYS A 56 1555 1555 2.12 SSBOND 3 CYS A 51 CYS A 95 1555 1555 2.03 SSBOND 4 CYS B 3 CYS B 71 1555 1555 2.01 SSBOND 5 CYS B 27 CYS B 56 1555 1555 2.12 SSBOND 6 CYS B 51 CYS B 95 1555 1555 2.02 SITE 1 AC1 8 LEU A 15 VAL A 16 TYR A 33 MET A 35 SITE 2 AC1 8 LEU A 41 TYR A 47 HOH A 480 LEU B 19 SITE 1 AC2 8 VAL A 16 LEU B 15 VAL B 16 TYR B 33 SITE 2 AC2 8 MET B 35 TYR B 47 THR B 77 HOH B 480 SITE 1 AC3 13 SER A 28 SER A 34 MET A 35 LEU A 36 SITE 2 AC3 13 HOH A 558 HOH A 596 HOH A 607 HOH A 666 SITE 3 AC3 13 HOH A 679 HOH A 703 PRO B 76 SER B 78 SITE 4 AC3 13 GLY B 79 SITE 1 AC4 10 THR B 14 ALA B 40 THR B 43 LEU B 66 SITE 2 AC4 10 ASN B 67 HOH B 500 HOH B 551 HOH B 598 SITE 3 AC4 10 HOH B 603 HOH B 668 SITE 1 AC5 5 GLN B 26 HOH B 499 HOH B 609 HOH B 650 SITE 2 AC5 5 HOH B 690 CRYST1 30.983 62.779 49.988 90.00 93.40 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.032276 0.000000 0.001918 0.00000 SCALE2 0.000000 0.015929 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020040 0.00000